AWMDMG
INO icon

Austin W. Marxe & David M. Greenhouse’s Inovio Pharmaceuticals INO Stock Holding History

Austin W. Marxe & David M. Greenhouse’s Portfolio INO Stock Details INO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2013
Q3 		– Sell
-12,466
Closed -$476K – 138
2013
Q2 		$476K Buy
+12,466
New +$378K 0.06% 120

Other funds holding INO

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Citigroup
Citigroup New York $235B AUM 32.99% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
California Public Employees Retirement System
California Public Employees Retirement System Sacramento, California $162B AUM 25.78% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Austin W. Marxe & David M. Greenhouse's INO Position: Q3 2013 in Review

Austin W. Marxe & David M. Greenhouse sold out of Inovio Pharmaceuticals (INO) in Q3 2013, closing a stake of 12,466 shares — an estimated $476K sold.

Austin W. Marxe & David M. Greenhouse first reported a position in INO in Q2 2013 and held it in 1 quarter. The position peaked at $476K in Q2 2013. 35 funds tracked by Wall St. Rank hold INO as of Q3 2013.

  • Austin W. Marxe & David M. Greenhouse reported no remaining Inovio Pharmaceuticals position as of Q3 2013 after selling out during the quarter.
  • Austin W. Marxe & David M. Greenhouse sold 12,466 Inovio Pharmaceuticals shares in Q3 2013, an estimated $476K.
  • Austin W. Marxe & David M. Greenhouse first reported a position in Inovio Pharmaceuticals in Q2 2013 and held it in 1 quarter.
  • Austin W. Marxe & David M. Greenhouse's Inovio Pharmaceuticals position peaked at $476K in Q2 2013.
  • 35 funds tracked by Wall St. Rank held Inovio Pharmaceuticals as of Q3 2013.

Based on Austin W. Marxe & David M. Greenhouse's 13F filing for Q3 2013, filed 8 Nov 2013.